| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |